Cabisay, Felecitas E.
HRN: 27-46-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2025
CEFTRIAXONE 1G (VIAL)
07/17/2025
07/24/2025
IV
2gms
OD
Acute Pyelonephritis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: